Katrina Thornber, Author at European Medical Journal - Page 48 of 50

Ruxolitinib Effective for Steroid-Refractory Graft-Versus-Host Disease

New findings indicate the potential of Ruxolitinib as an effective treatment for steroid-refractory acute graft-versus-host disease.

Plants for Joints Trial: Breaking News from EULAR 2024

Results presented at EULAR 2024, show reductions in DAS28 scores among rheumatoid arthritis patients following a plant-based, whole-food diet, exercise, and stress management regime.

EULAR Breaking News: Interferon Signature in Paediatric Sjögren’s Diagnosis

Researchers presented novel findings on the potential utility of the blood interferon signature in diagnosing and stratifying paediatric Sjögren’s disease.

Who is More at Risk of Adverse Events After Coronary Procedures?

New study highlights the need for targeted anti-inflammatory treatments to reduce adverse cardiovascular events in high-risk patients.

Pre-eclampsia Linked to Congenital Heart Disease in Newborns

A significant association has been established between pre-eclampsia and congenital heart disease in offspring.

Novel Blood Biomarkers for Mortality Risk in General Population

Recent research has revealed that the red blood cell distribution width to albumin concentration ratio is associated with increased all-cause and cause-specific mortality.

Long-Term Risks of β-lactam Allergies

An increased risk of antibiotic-resistant infections, for up to 12 years, is associated with β-lactam allergies, according to recent research.

Sodium Intake Associated with Atopic Dermatitis

Reduced intake of dietary sodium may be a cost-effective and low-risk treatment for atopic dermatitis (AD), according to recent research.

Vitamin C Associated with Improved Survival in Low-Risk Myeloid Malignancies

Results from a trial on the use of vitamin C supplementation for the treatment of low-risk myeloid malignancies were presented at the 2024 European Haematology Association Congress

Oral Contraceptive Pill Associated With Alopecia

A study shows oral contraceptive pill use affects the protective effect of the CYP1B1 variant against frontal fibrosing alopecia, increasing risk in females with OCP history.